TY  - GEN
AU  - Else,Monica
AU  - Marín-Niebla,Ana
AU  - de la Cruz,Fátima
AU  - Batty,Paul
AU  - Ríos,Eduardo
AU  - Dearden,Claire E
AU  - Catovsky,Daniel
AU  - Matutes,Estella
TI  - Rituximab, used alone or in combination, is superior to other treatment modalities in splenic marginal zone lymphoma
SN  - 1365-2141
PY  - 2012///1218
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antibodies, Monoclonal, Murine-Derived
KW  - administration & dosage
KW  - Antineoplastic Agents
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Disease Progression
KW  - Female
KW  - Humans
KW  - Lymphoma, B-Cell, Marginal Zone
KW  - drug therapy
KW  - Male
KW  - Middle Aged
KW  - Rituximab
KW  - Splenic Neoplasms
KW  - Treatment Outcome
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1111/bjh.12036
ER  -